Nose spray to treat depression? FDA approves first-of-its-kind medicine
A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced ...
FDA Approves Johnson & Johnson's Treatment As First Monotherapy For Treatment-Resistant ...
On Tuesday, the FDA approved Johnson & Johnson’s (NYSE:JNJ) supplemental New Drug Application for Spravato (esketamine) CIII ...
FDA approves standalone use of J&J's ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...